CIRM’s Discovery Stage Research program funds collaborative, innovative basic research to advance breakthroughs in regenerative medicine and stem cell biology, focusing on foundational science and early-stage discoveries.
CLIN2 Awards: Funding Opportunity for Clinical Trials supports organizations conducting stem cell-based or genetic therapy trials to address serious unmet medical needs and advance toward marketing approval.
MSCRF Discovery Program supports academic scientists in Maryland conducting basic and translational human stem cell research to advance understanding and treatment of human diseases, injuries, and conditions.
Data Science and Software Engineering (INFR9) Awards support interdisciplinary teams developing open source tools to integrate multimodal data and accelerate stem cell-based and genetic therapy research.
Preclinical Development supports researchers developing stem cell-based and genetic therapies, funding candidate optimization, preclinical studies, and trial startup to advance toward first-in-human trials.
MSCRF Clinical Program supports organizations conducting human stem cell-based clinical research in Maryland to advance therapies for human diseases, injuries, and conditions and address unmet medical needs.